|
Real-time Estimate
Cboe BZX
14:37:59 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 10.16 USD | +2.42% |
|
+0.92% | +27.18% |
| 08-25 | BioCryst Pharmaceuticals Announces Approval Of ORLADEYO For Pediatric HAE Patients In Japan | CI |
| 08-25 | BioCryst Pharmaceuticals Gets Japan Approval for Orladeyo in Young Children | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.42% | +0.92% | +10.47% | +15.75% | +27.18% | +19.37% | +36.26% | -38.58% | +138.46% | 2.53B | |
| -0.25% | -4.10% | +20.22% | +54.42% | +70.34% | +38.38% | +92.61% | +16.28% | - | 68.21B | |
| +3.72% | +2.41% | +27.28% | +32.45% | +28.24% | +51.68% | +93.56% | +213.72% | +6,364.14% | 64.25B | |
| +2.97% | -1.92% | +23.24% | +14.60% | -30.18% | -10.72% | +436.70% | +317.13% | +807.47% | 26.54B | |
| +2.52% | -10.61% | +12.55% | +11.17% | +7.09% | +1.95% | -16.27% | -69.34% | - | 25.61B | |
| +3.31% | +1.57% | +18.80% | +41.99% | +8.19% | +32.75% | -17.65% | -28.38% | +109.06% | 19.88B | |
| -6.09% | -12.08% | +23.58% | +51.06% | +209.18% | +226.11% | +375.00% | +1,801.66% | +854.21% | 17.13B | |
| +0.65% | -5.28% | +3.40% | +22.15% | +25.70% | -1.12% | +534.90% | - | - | 14.93B | |
| +3.45% | +0.30% | +7.28% | +13.15% | +29.80% | +52.03% | +150.18% | +191.15% | +401.23% | 14.1B | |
| +2.21% | +5.18% | +15.28% | +11.94% | -7.49% | +23.04% | +190.97% | +543.93% | +4,434.60% | 12.45B | |
| +2.29% | -6.91% | -2.26% | +10.03% | +24.63% | +275.58% | +195.92% | +20.81% | +1,071.95% | 11.69B | |
| +3.32% | +5.99% | +8.76% | -9.87% | -19.04% | -40.25% | +768.71% | +94.51% | +112.96% | 11.3B | |
| +2.83% | -7.82% | -7.43% | -3.09% | +12.37% | +102.09% | +98.33% | +116.23% | +580.00% | 9.93B | |
| +2.02% | -0.46% | +12.44% | +24.33% | +31.79% | +97.50% | +14.52% | +125.89% | - | 9.05B | |
| +4.83% | -3.91% | +9.76% | +8.70% | +297.47% | +236.32% | +414.38% | -33.31% | - | 8.34B | |
| +1.31% | -17.57% | -10.00% | +25.46% | +170.15% | +436.69% | +510.34% | -51.17% | -38.81% | 7.8B | |
| -2.58% | -4.82% | -2.43% | +21.62% | +4.18% | -7.25% | +253.08% | +275.30% | - | 7.26B | |
| -2.45% | +3.14% | +0.67% | -21.76% | -49.19% | - | - | - | - | 6.83B | |
| -0.01% | -3.95% | -6.09% | -3.79% | +1.80% | +12.61% | +53.43% | +11.81% | +163.76% | 6.84B | |
| +3.77% | -4.05% | +18.17% | +17.94% | +26.88% | +71.18% | +788.55% | +41.10% | - | 6.81B | |
| Average | +1.47% | -3.84% | +9.18% | +16.91% | +43.45% | +85.15% | +261.77% | +197.15% | +1,249.92% | 17.57B | |
| Weighted average by Cap. | +1.59% | -3.39% | +15.37% | +26.90% | +41.82% | +63.37% | +200.89% | +201.50% | +2,586.18% |
- Stock Market
- Stocks
- BCRX Stock
- Sector BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
